Search
Pluri Inc
PLURAdd to Watchlist
1.550USD
-0.010-0.64%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.17MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Pluri Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
12.000
Target Price
+397.93%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Pluri Inc
PLUR
0
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Pluri Inc's expected revenue for the next quarter?
Pluri Inc's expected revenue is 655.00K.
What is Pluri Inc's price target?
Analysts forecast that Pluri Inc's price target is USD 12.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 12.00.
How have Pluri IncPLUR's recent earnings per share performed?
The market expectation was USD -0.55, while Pluri IncPLUR's earnings per share (EPS) for the previous quarter was USD -0.71. EPS for the next quarter is expected at USD -0.66.